Calidi Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (CLDI)

Q: What does CUSIP 320703309 represent in this 13F holders report?

CUSIP 320703309 is the security identifier for CLDI - Calidi Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held CLDI - Calidi Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share in Q4 2025?

No institutional holders were reported for CLDI - Calidi Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share in Q4 2025; review adjacent reporting periods for trend context.

CUSIP: 320703309

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 33,630,240
Total 13F shares: 0
Share change: -21,074
Total reported value: $0
Price per share: $0.59
Number of holders: 0
Value change: -$31,797
Number of sells: 2

Quarterly Holders Quick Answers

What is CUSIP 320703309?
CUSIP 320703309 identifies CLDI - Calidi Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q3 2025

Recent filing periods for CUSIP 320703309:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Calidi Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (CLDI)

Q4 2025 13F Holders as of 31 Dec 2025

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of CLDI - Calidi Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q4 2025.